On the Pathological Relevance and Diagnostic Value of Alpha Synuclein as Novel Biomarker in Autism

Right now, there is no known treatment for autism spectrum disorders (ASD). Interventions to lessen the symptoms include behavioural and speech therapies. The synaptic activities of neurons depend on the presynaptic neurotransmitters. Neurotransmitter release, which transports impulses between neurons, is essential for healthy brain function. Although alpha synuclein’s role is not fully known, research points to a critical part it may play in ensuring that presynaptic terminals have a sufficient